Thyrocare Technologies Limited has informed the Exchange that a conference call for the analysts/ investors is arranged by our management to discuss the Company's Unaudited Financial Results for the quarter and nine months ended December 31, 2025, on Wednesday, January 28, 2026, at 5:30 P.M (IST).
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Thyrocare Technologies has scheduled a conference call with analysts and investors on Wednesday, January 28, 2026, at 5:30 P.M. IST. The call will be hosted by the company's management to discuss the unaudited financial results for the quarter and nine months ended December 31, 2025. This is a standard pre-results engagement typically held shortly before or after the official earnings filing.
No direct impact on shareholders. Investors should watch for the upcoming Q3 FY26 results announcement, which may give clarity on the company's revenue, profit, and growth trajectory heading into the final quarter of the fiscal year.